Dr Martin Hirst appointed Director of the Michael Smith Laboratories

Dr. Martin Hirst has been a faculty member since 2015 when UBC’s Centre for High-Throughput Biology (CHiBi) merged with the MSL. His research focuses on understanding the role of the epigenome in normal development and disease while aiming to improve health outcomes for Canadians. Cross appointed with the Department of Microbiology and Immunology and Canada’s Michael Smith Genome Sciences Centre, Dr. Hirst brings a wealth of experience in genomic research and technology to his leadership role.